Nebulizers Market Share and Size Analysis by 2031
市场洞察和分析师观点:
雾化器市场预测是根据各种二级和一级研究的结果得出的来源。
雾化器是一种用于输送各种药物的设备,以帮助控制呼吸问题,例如喘息和松弛肺部分泌物。它将液体药物转化为细小的液滴,然后通过面罩或吸嘴吸入,药物可以通过面罩或吸嘴直接进入肺部。与其他吸入器不同,雾化器使用由插座供电的空气压缩机。
影响雾化器市场增长的驱动因素和限制
近年来,由于技术的进步,家庭医疗保健设备变得越来越受欢迎。技术和产品小型化。这导致家庭医疗保健设备的采用率上升。此外,老年人口数量不断增加、慢性肾病(CRD)发病率高、医疗服务和住院费用不断上涨,导致人们越来越倾向于在家庭护理环境中治疗患者。由于有适合家庭使用的紧凑、便携式和患者友好型雾化器,再加上可降低噪音和改进功能的技术创新,家庭医疗保健是替代昂贵住院治疗的一种经济实惠的选择。此外,还有多种雾化制剂可供选择,包括长效 β2 激动剂 (LABA)、长效毒蕈碱受体拮抗剂、类固醇、抗生素和粘液溶解剂。最近在市场上推出的一些家用产品如下:
2023 年 1 月,Synergy Life Science, Inc. 推出了 Nebi,这是一款靠电池供电的袖珍雾化器,适用于各种应用。2021 年 7 月,HCmed Innovations 的 Pulmogine 振动网雾化器获得美国食品和药物管理局 (FDA) 批准。该设备便携且易于使用,使其成为需要吸入治疗的患者的便捷解决方案。 2020 年 6 月,Respira Technologies, Inc. 推出了 RespiRx 药物输送设备平台。这个新颖的平台是一款超便携式手持式振动网雾化器 (VMN),用于各种目标适应症的局部和全身治疗,包括哮喘和慢性阻塞性肺病。这些发展将雾化器的使用范围从诊所或医院的急症护理环境扩展到家庭护理环境.
但是,社区缺乏对哮喘的认识和认识、获得医疗保健的机会较差、医疗保健系统紧张、缺乏包括肺活量测定在内的诊断测试、医疗保健提供者缺乏培训以及缺乏不执行哮喘指南的制定都是导致哮喘诊断不足的主要因素。哮喘诊断不足进一步导致患者服用不正确的药物来治疗病情,临床结果不佳,预计这反过来会阻碍市场增长。尽管哮喘在世界范围内的患病率不断增加,但人们对这些疗法的接受度仍然较低,因为人们更倾向于阿育吠陀和自制药物。治疗哮喘和慢性阻塞性肺疾病(COPD)的指南发生了显着变化。单独吸入皮质类固醇(ICS)或与长效β2受体激动剂(LABA)联合使用是哮喘的一线治疗方法,而单独或与长效β2受体激动剂(LABA)联合使用长效毒蕈碱拮抗剂是慢性阻塞性肺病(COPD)的一线治疗方法。由于这种特定的组合,先进的便携式雾化器的成本增加。根据 Pubmed Central 2020 年 9 月发表的一篇文章,开展了一项研究,以评估在实际环境中静脉注射甲泼尼龙和雾化布地奈德治疗慢性阻塞性肺疾病急性加重 (AECOPD) 的成本效益。该研究得出的结论是,对于中国的 AECOPD 患者来说,与静脉注射甲泼尼龙相比,雾化布地奈德并不是一种具有成本效益的治疗方法。因此,缺乏早期诊断和雾化治疗的高成本阻碍了雾化器的增长。
报告细分和范围:
“全球雾化器市场分析”到 2031 年”是一项专门且深入的研究,重点关注全球市场动态,以帮助确定市场中的关键驱动因素、未来趋势和利润丰厚的机会,从而有助于确定主要收入来源。该报告旨在提供市场概况,并按类型、应用程序和最终用户进行详细的市场细分。雾化器市场报告的范围涉及北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和其他地区)南美洲和中美洲)。
细分分析:
按类型划分,市场分为喷射雾化器、超声波雾化器和网状雾化器。喷射雾化器细分市场在 2022 年占据最大的市场份额。网状雾化器细分市场预计在 2023 年至 2031 年期间复合年增长率最高。喷射雾化器是一种价格实惠且易于使用的设备,可以以气雾剂的形式输送药物。它们专为一次性使用而设计,无需灭菌并降低污染风险。喷射雾化器常用于机械通气过程中。这些雾化器在 CRD 治疗中的各种应用正在推动预测期内喷射雾化器的市场规模。
按类型划分的雾化器市场 - 2023 年和 2031 年
按应用划分的市场是分为慢性阻塞性肺病、哮喘、囊性纤维化等。预计 COPD 细分市场将在 2023 年占据最大的雾化器市场份额。预计哮喘细分市场在 2023 年至 2031 年期间将以最高的复合年增长率增长。慢性阻塞性肺病是一种慢性炎症性肺部疾病,会导致肺部气流受阻。症状包括呼吸困难、咳嗽、产生粘液(痰)和喘息。它通常是由于长期接触刺激性气体或颗粒物(最常见的是香烟烟雾)引起的。患有慢性阻塞性肺病的人患心脏病、肺癌和各种其他疾病的风险增加。据世界卫生组织 (WHO) 称,慢性阻塞性肺病是全球第三大死因。随着呼吸系统疾病负担的增加,对吸入疗法的需求也在增加。此外,对家庭护理治疗偏好的转变推动了手持式雾化器用于治疗慢性阻塞性肺病和哮喘的使用。
根据最终用户,雾化器市场分为医院和诊所、急救中心和家庭护理设置。医院和诊所细分市场在 2023 年占据最大市场份额,由于各种类型雾化器的医疗可用性以及这些设备在医院环境中的采用率不断增长,预计 2023 年至 2030 年复合年增长率最高。
地区展望:
北美在 2023 年占据最大的雾化器市场份额。由于慢性阻塞性肺病 (COPD) 患病率不断增加,美国在 2023 年占据该地区最大的市场份额,其次是加拿大以及该地区人们的哮喘病。根据 Merck Sharp & Dohme (MSD) 手册中发表的一篇文章,约有 1600 万人患有慢性阻塞性肺病 (COPD),这是导致死亡的主要原因,在美国每年夺走超过 15 万人的生命。推动北美雾化器市场增长的其他因素包括医疗保健领域先进设备的引入、医疗保健支出的增加以及欧姆龙医疗保健、BD 和 GE Healthcare 等领先市场参与者在该地区的存在。
< br>行业发展和未来机遇:
根据公司新闻稿,全球雾化器市场主要参与者采取的一些举措如下:
“2021 年 12 月, Cipla Limited 推出了一项举措,旨在改善印度农村初级保健中心获得雾化治疗来治疗急性哮喘的机会,该中心在整个护理过程中广泛存在,并提供广泛的药物设备组合和治疗。2021 年 3 月,PARI Pharma GmbH推出了LAMIRA雾化器系统,该系统已被授权在日本提供ARIKAYCE(阿米卡星脂质体吸入混悬液)。该系统采用基于 eFlow 技术的先进气雾剂输送系统,并具有可容纳 8.4 毫升全剂量的定制药物储存器。2021 年 3 月,欧姆龙医疗保健公司和美国哮喘和过敏基金会 (AAFA)合作提供医疗级雾化器,以支持 AAFA 的宣传和举措,以传播帮助哮喘社区最弱势成员的意识。竞争格局和主要公司:
OMRON Healthcare, Inc.;皇家飞利浦公司;帕里有限公司;维克图拉集团有限公司;驾驶德维尔比斯国际机场;布里格斯医疗保健; GF 健康产品公司;通用电气医疗保健;安捷伦科技公司;泰尔茂公司;和 Trudell Medical International 是雾化器市场报告中介绍的知名公司之一。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The nebulizers market was valued at US$ 815.88 million in 2023.
Key factors driving the nebulizers market growth are the surging prevalence of chronic respiratory diseases and increasing demand for respiratory devices for home care settings are driving the growth of the market.
A nebulizer is a device used to deliver various medicines to help control breathing problems such as wheezing and loosen lung secretions. It converts liquid medicine into fine droplets, which are then inhaled through a mask or mouthpiece through which the medicine can enter directly into the lungs. Unlike other inhalers, nebulizers use an air compressor powered by electricity from an outlet.
Based on type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers.
The nebulizers market majorly consists of the players, including Baxter; B. Braun Medical Inc.; BD; Cantel Medical; DaVita Inc.; Fresenius Medical Care; Medtronic; Nikkiso Co., Ltd.; Asahi Kasei Corporation; and Terumo Corporation.
The nebulizers market is expected to be valued at US$ 1315.57 million in 2031.
The List of Companies - Nebulizers Market
- OMRON Healthcare, Inc
- Koninklijke Philips N.V.
- PARI GmbH
- Vectura Group Ltd
- Drive DeVilbiss International
- Briggs Healthcare
- GF Health Products, Inc.
- GE Healthcare
- Agilent Technologies, Inc
- Terumo Corporation
- Trudell Medical International
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.